Drug-Eluting Balloon Registry in Routine Clinical Practice (IRIS DEB)
Evaluation of Effectiveness and Safety of Drug-Eluting Balloon in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study
Sponsor: B. Braun Korea Co., Ltd.
A observational or N/A phase clinical study on Angioplasty, Balloon and Coronary Artery Disease, this trial is actively recruiting participants. The trial is conducted by B. Braun Korea Co., Ltd. and has accumulated 16 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
16 versions recorded-
Jan 2026 — Present [monthly]
Recruiting
-
Sep 2025 — Jan 2026 [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Recruiting
▶ Show 11 earlier versions
-
Jul 2023 — Jan 2024 [monthly]
Recruiting
-
Jul 2022 — Jul 2023 [monthly]
Recruiting
-
Oct 2021 — Jul 2022 [monthly]
Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Jan 2020 — Jan 2021 [monthly]
Recruiting
-
Jul 2018 — Jan 2020 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- B. Braun Korea Co., Ltd.
- CardioVascular Research Foundation, Korea
- Seung-Jung Park
For direct contact, visit the study record on ClinicalTrials.gov .